GRP78-targeted and doxorubicin-loaded nanodroplets combined with ultrasound: a potential novel theranostics for castration-resistant prostate cancer.
GRP78-targeted and doxorubicin-loaded nanodroplets combined with ultrasound: a potential novel theranostics for castration-resistant prostate cancer.
复制标题
GRP78 靶向和阿霉素负载纳米液滴与超声相结合:一种治疗去势抵抗性前列腺癌的潜在新型治疗诊断学。
DOI:
10.1080/10717544.2021.2023698
复制
发表时间:
2022-12
期刊:
影响因子:
6
通讯作者:
Li J
中科院分区:
文献类型:
--
作者:
Zhao Y;Shi D;Shang M;Sun X;Guo L;Meng D;Liu X;Zhou X;Li J
The construction of multifunctional oncotherapy nanoplatforms that combine diagnosis and treatment remains challenging. Nanodroplets (NDs), which simultaneously enhance ultrasound imaging and therapeutic effects, are a potential strategy for non-invasive drug delivery. To achieve the goals of precise medicine, novel SP94 peptide-modified and doxorubicin-loaded ultrasonic NDs (SP94-DOX-NDs) for castration-resistant prostate cancer (CRPC) targeting and treatment were constructed in this study. The characteristics, contrast-enhanced ultrasound imaging (CEUI), targeting ability to glucose-regulated protein 78 (GRP78)-overexpressing CRPC and anticancer effect of the SP94-DOX-NDs were assessed. The desired SP94-NDs were successfully prepared using the nanoemulsification method using a certain proportion of SP94-PEG-chitosan, perfluoropentane (PFP), Tween 20, and lecithin. SP94-NDs with a size of ∼300 nm showed great biocompatibility and CEUI ability. Compared with blank NDs, SP94-NDs exhibited higher tumor-specific targeting ability due to conjugation between the SP94 peptide and GRP78-overexpressing 22RV1 cells. Most importantly, in vitro and in vivo investigations showed that SP94-DOX-NDs combined with ultrasound could specifically deliver DOX into 22RV1 cells and thereby demonstrated a stronger anticancer effect than DOX-NDs and DOX. Thus, SP94-DOX-NDs may provide an efficient approach for the real-time imaging of tumors and triggered, accurate drug delivery to tumors.
登录
查看更多内容
影响因子:
14
作者:
Du, Yong-Zhong;Cai, Li-Li;Hu, Fu-Qiang
通讯作者:
Hu, Fu-Qiang
影响因子:
4
作者:
Chen, Jiangwei;Lin, Zunwen;Yang, Dong
通讯作者:
Yang, Dong
影响因子:
10
作者:
Lv, Yongjiu;Cao, Yang;Zhang, Liangke
通讯作者:
Zhang, Liangke
影响因子:
14
作者:
Wang, Chung-Hsin;Kang, Shih-Tsung;Yeh, Chih-Kuang
通讯作者:
Yeh, Chih-Kuang
影响因子:
8.4
作者:
Duan, Sujuan;Guo, Lu;Li, Jie
通讯作者:
Li, Jie